# Improving Informed Consent for Early Phase Anti-Cancer Trials

> **NCT04407676** · NA · UNKNOWN · sponsor: **Royal Marsden NHS Foundation Trust** · enrollment: 34 (estimated)

## Conditions studied

- Solid Neoplasms

## Interventions

- **OTHER:** Summary PIS and Online Video Modules

## Key facts

- **NCT ID:** NCT04407676
- **Lead sponsor:** Royal Marsden NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06-26
- **Primary completion:** 2022-11-26
- **Final completion:** 2023-03-26
- **Target enrollment:** 34 (ESTIMATED)
- **Last updated:** 2022-03-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04407676

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04407676, "Improving Informed Consent for Early Phase Anti-Cancer Trials". Retrieved via AI Analytics 2026-06-14 from https://api.ai-analytics.org/clinical/NCT04407676. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*